Download MendeleyMacrocyclic Aminopyrimidines as Multitarget Cdk and Vegf-R Inhibitors with Potent Antiproliferative Activities.
Luecking, U., Siemeister, G., Schaefer, M., Briem, H., Krueger, M., Lienau, P., Jautelat, R.(2007) ChemMedChem 2: 63
- PubMed: 17131463
- DOI: https://doi.org/10.1002/cmdc.200600199
- Primary Citation of Related Structures:
2J9M - PubMed Abstract:
X-ray structures from CDK2-aminopyrimidine inhibitor complexes led to the idea to stabilize the active conformation of aminopyrimidine inhibitors by incorporating the recognition site into a macrocyclic framework. A modular synthesis approach that relies on a new late-stage macrocyclization protocol that enables fast and efficient synthesis of macrocyclic aminopyrimidines was developed. A set of structurally diverse derivatives was prepared. Macrocyclic aminopyrimidines were shown to be multitarget inhibitors of CDK1/2 and VEGF-RTKs. In addition, potent antiproliferative activities toward various human tumor cells and a human tumor xenograft model were demonstrated.
Organizational Affiliation:
Medicinal Chemistry, Research Center Europe, Schering AG, 13342 Berlin, Germany. ulrich.luecking@schering.de
